Presence of rare potential pathogenic variants in subjects under 65 years old with very severe or fatal COVID-19Rosario López‐Rodríguez, Antonio Moreno‐Docón, Lorena Ondo et al.|Scientific Reports|2022Cited by 11
Age-dependent association of clonal hematopoiesis with COVID-19 mortality in patients over 60 yearsMarta Del Pozo‐Valero, José‐María Abellán‐Perpiñán, Marta Cortón et al.|GeroScience|2022Cited by 10
A specific natural killer cells phenotypic signature associated to long term elite control of HIV infectionNorma Rallón, José M. Benito, Daniel Jiménez‐Carretero et al.|Journal of Medical Virology|2024Cited by 10
PTCH1 is a reliable marker for predicting imatinib response in chronic myeloid leukemia patients in chronic phaseJuan Manuel Alonso‐Domínguez, Joaquín Martínez‐López, Luis Felipe Casado et al.|PLoS ONE|2017Cited by 10
Meningoencefalitis criptocócica. Epidemiología y factores de riesgo de mortalidad en la era pre - y pos-TARGAAlfonso Cabello, Manuel L. Fernández Guerrero, José Fortes Alen et al.|Medicina Clínica|2016Cited by 6